Dortmund-based iDEL Therapeutics raises €9M in seed funding to build a pipeline of next-generation targeted cancer therapeutics.
Browsing: Science
Habitasse platea dictumst vestibulum rhoncus est pellentesque elit. Enim diam vulputate ut pharetra sit amet aliquam id.
Level Nine secures €4M to develop AI-designed nanozyme catalysts that convert biomass into chemicals, aiming to help rescue Europe’s struggling €1T chemical industry.
London’s Ternary Therapeutics raises €4.1M seed round to advance an AI-driven platform targeting next-generation precision medicines.
Utrecht-based Scinus has secured €3M to industrialise cell therapy manufacturing, aiming to cut costs and improve safety with its bioreactor and process automation tech.
Norwich-based Tropic raises an oversubscribed €91.3M round to accelerate gene‑edited tropical crops aimed at boosting yields, resilience and food security.
Owkin spinout Waiv raises $33M to turn routine pathology slides into rapid AI-powered precision oncology tests for labs worldwide.
German climate-tech startup AIRMO secures €5M to launch satellites that detect unreported methane emissions, helping industries and governments cut greenhouse gases.
VALANX Biotech secures €3M to push its lead antibody-drug conjugate program toward safer, more precise cancer treatment.
Bladder cancer innovator Combat Medical has raised £2.6M to hit a key phase 3 milestone, accelerating development of its heat-enhanced intravesical therapy.
French startup Mantle8 secures a €2.06M EU Just Transition Fund grant to accelerate natural hydrogen exploration and support Europe’s low-carbon energy transition.